Rajesh J Asarpota appointed as Nuvasive’s chief financial officer

412

NuVasive has announced the appointment of Rajesh (Raj) J Asarpota as the company’s new executive vice president and chief financial officer (CFO), effective September 1, 2017.

As a member of NuVasive’s global executive team, Asarpota will be responsible for the company’s global finance functions including accounting, FP&A, treasury and tax. He joins NuVasive with experience in financial and executive leadership roles across the healthcare industry.

Asarpota began his career at General Electric (GE) in the GE Financial Management program. This included finance roles in commercial operations, plant and manufacturing analysis, sourcing and research & development analysis. He then joined the GE Corporate Audit Staff programme, and from there moved to GE Healthcare. In the last 15 years, he has accumulated experience in both public and private enterprises, including a decade-long tenure at Life Technologies. More recently, Asarpota was the chief financial officer of publicly-traded Questcor Pharmaceuticals and supported the sale of that company. He then worked in private equity-backed healthcare companies, performing executive financial and operational roles.

“Raj brings a strong financial and operational background to the NuVasive leadership team as we continue to focus on driving revenue growth and expanding profitability,” says Gregory T Lucier, NuVasive’s chairman and chief executive officer. “I have worked closely with Raj at multiple companies where we were successful at expanding market share and transforming operations. He is a proven leader who will drive significant shareholder value.”

Asarpota earned a bachelor’s degree from the University of Bombay in Bombay, India (now Mumbai University, Mumbai, India). He attained a masters of business administration at Marquette University in Milwaukee, USA.

(Visited 83 times, 1 visits today)

LEAVE A REPLY

Please enter your comment!
Please enter your name here